# Allurion Technologies, Inc. (ALUR)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/allurion-technologies-inc/ JSON: https://steadybase.io/company/allurion-technologies-inc.json Checked Nov 10, 2026. Latest filing read: May 15, 2026.

## Company

- Legal name: ALLURION TECHNOLOGIES, INC.
- Ticker: ALUR (OTC)
- SEC CIK: 0001964979
- Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
- Headquarters: Natick, MA
- Fiscal year ends: December 31
- SEC filer category: <br>Emerging growth company
- Website: allurion.com
- LinkedIn: https://www.linkedin.com/company/allurion-technologies
- Next earnings date: Jan 11, 2027 (estimated from past 8-K timing)

## Key facts

- Revenue: $15.2M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 30, 2026). Source: https://www.sec.gov/Archives/edgar/data/1964979/000119312526130483/0001193125-26-130483-index.html
- Operating income: -$30.2M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 30, 2026). Source: https://www.sec.gov/Archives/edgar/data/1964979/000119312526130483/0001193125-26-130483-index.html
- Net income: -$28.8M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 30, 2026). Source: https://www.sec.gov/Archives/edgar/data/1964979/000119312526130483/0001193125-26-130483-index.html
- SG&A: $32.2M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 30, 2026). Source: https://www.sec.gov/Archives/edgar/data/1964979/000119312526130483/0001193125-26-130483-index.html
- Employees: 41 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1964979/000119312526130483/alur-20251231.htm
- Shares outstanding: 15,006,253 as of May 12, 2026 (10-Q filed May 15, 2026). Source: https://www.sec.gov/Archives/edgar/data/1964979/000119312526226960/0001193125-26-226960-index.html
- Auditor: Deloitte & Touche LLP, Boston, Massachusetts, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1964979/000119312526130483/alur-20251231.htm

## Business

Our company is pioneering metabolically healthy weight loss by creating a best-in-class weight loss platform to treat the estimated two billion people globally who are overweight. Our platform, the Allurion Program (the "Allurion Program"), features the world’s first and only swallowable, ProcedurelessTM intragastric balloon for weight loss (the "Allurion Smart Capsule") and offers access to artificial intelligence ("AI")-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging and video telehealth that make up the Allurion Virtual Care Suite (“VCS”).

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/1964979/000119312526130483/alur-20251231.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $15.2M | -$30.2M | -$28.8M | $32.2M |
| Dec 31, 2024 | $32.1M | -$50.2M | -$7.2M | $54.3M |
| Dec 31, 2023 | $53.5M | -$79.1M | -$82.8M | $92.9M |
| Dec 31, 2022 | $64.2M | -$32.0M | -$37.7M | $65.8M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/allurion-technologies-inc.json

## Officers and directors

- Shantanu Gaur, Chief Executive Officer and President (Principal Executive Officer and Principal Financial Officer). Source: 10-Q filed May 15, 2026, https://www.sec.gov/Archives/edgar/data/1964979/000119312526226960/alur-ex31_1.htm
- Ojas Buch, Chief Operating Officer. Source: 8-K filed Jul 23, 2026, https://www.sec.gov/Archives/edgar/data/1964979/000119312526314263/alur-20260717.htm
- Brendan M. Gibbons, Chief Legal Officer. Source: Form 5 filed Feb 17, 2026, https://www.sec.gov/Archives/edgar/data/1964979/000119312526055067/0001193125-26-055067-index.htm
- Keith Johns, Director. Source: 10-K filed Mar 30, 2026, https://www.sec.gov/Archives/edgar/data/1964979/000119312526130483/alur-20251231.htm
- Nicholas Lewin, Director. Source: 10-K filed Mar 30, 2026, https://www.sec.gov/Archives/edgar/data/1964979/000119312526130483/alur-20251231.htm
- Brendan Gibbons, Named in proxy. Source: DEF 14A filed Nov 24, 2025, https://www.sec.gov/Archives/edgar/data/1964979/000119312525293675/d923025ddef14a.htm
- Shantanu Gaur, M.D., Board member (per proxy). Source: DEF 14A filed Nov 24, 2025, https://www.sec.gov/Archives/edgar/data/1964979/000119312525293675/d923025ddef14a.htm

## Recent 8-K events

- Aug 24, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/1964979/000119312526363811/alur-20260817.htm
- Jul 24, 2026: Item 1.01, Entry into a material definitive agreement; Item 1.02, Termination of a material definitive agreement; Item 3.02, Unregistered sales of equity securities; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1964979/000119312526316202/alur-20260721.htm
- Jul 23, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/1964979/000119312526314263/alur-20260717.htm
- Jul 7, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/1964979/000119312526296918/alur-20260630.htm
- Jun 30, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/1964979/000119312526290772/alur-20260624.htm
- Jun 17, 2026: Item 3.03, Material modification to rights of security holders; Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1964979/000119312526274250/alur-20260612.htm
- May 27, 2026: Item 4.01, Changes in registrant's certifying accountant; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1964979/000119312526242009/alur-20260520.htm
- Mar 12, 2026: Item 3.01, Notice of delisting or failure to meet listing standards; Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1964979/000119312526104434/alur-20260306.htm
- Mar 2, 2026: Item 3.01, Notice of delisting or failure to meet listing standards; Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1964979/000119312526084412/d39723d8k.htm
- Feb 25, 2026: Item 1.01, Entry into a material definitive agreement; Item 3.02, Unregistered sales of equity securities; Item 3.03, Material modification to rights of security holders; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1964979/000119312526068667/alur-20260224.htm

## Insider trades (Form 4)

- Dec 4, 2025: Michael R. Davin (Director) sold 3,212 shares, about $4,914. Source: https://www.sec.gov/Archives/edgar/data/1964979/000119312525310088/0001193125-25-310088-index.htm

## What management said

- "We are pleased with our results from the fourth quarter, where we grew revenue meaningfully quarter-over-quarter for the first time in more than one year as our new commercial strategy implemented after our strategic pivot in 2025 began to take hold" Dr. Shantanu Gaur, Founder and Chief Executive Officer (8-K filed Jan 12, 2026). Source: https://www.sec.gov/Archives/edgar/data/1964979/000119312526010462/alur-ex99_1.htm

## Latest filings

- 8-K filed Aug 24, 2026: https://www.sec.gov/Archives/edgar/data/1964979/000119312526363811/alur-20260817.htm
- 10-K filed Mar 30, 2026: https://www.sec.gov/Archives/edgar/data/1964979/000119312526130483/alur-20251231.htm
- 10-Q filed May 15, 2026: https://www.sec.gov/Archives/edgar/data/1964979/000119312526226960/alur-20260331.htm
- DEF 14A filed Nov 24, 2025: https://www.sec.gov/Archives/edgar/data/1964979/000119312525293675/d923025ddef14a.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/